| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |